vs
ANGIODYNAMICS INC（ANGO）与Resolute Holdings Management, Inc.（RHLD）财务数据对比。点击上方公司名可切换其他公司
Resolute Holdings Management, Inc.的季度营收约是ANGIODYNAMICS INC的1.5倍（$117.7M vs $79.4M），Resolute Holdings Management, Inc.净利率更高（-1.5% vs -8.0%，领先6.5%），Resolute Holdings Management, Inc.自由现金流更多（$189.2M vs $4.2M）
AngioDynamics是一家全球医疗技术企业，专注于研发、生产及销售微创医疗设备，核心产品覆盖血管通路、外科消融、肿瘤治疗等领域，面向北美、欧洲、亚太地区的医院、门诊手术中心及各类医疗机构提供服务。
Resolute Holdings Management, Inc.是一家澳大利亚矿业企业，核心业务布局于非洲地区，目前运营两座金矿，分别为位于马里的 Syama 金矿和塞内加尔的 Mako 金矿，专注于黄金资源的勘探、开采及相关运营管理工作。
ANGO vs RHLD — 直观对比
营收规模更大
RHLD
是对方的1.5倍
$79.4M
净利率更高
RHLD
高出6.5%
-8.0%
自由现金流更多
RHLD
多$185.0M
$4.2M
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $79.4M | $117.7M |
| 净利润 | $-6.3M | $-1.7M |
| 毛利率 | 56.4% | 55.7% |
| 营业利润率 | -7.7% | 30.2% |
| 净利率 | -8.0% | -1.5% |
| 营收同比 | 9.0% | — |
| 净利润同比 | 40.9% | — |
| 每股收益（稀释后） | $-0.15 | $-0.20 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ANGORHLD
| Q4 25 | $79.4M | $117.7M | ||
| Q3 25 | $75.7M | $120.9M | ||
| Q2 25 | $80.2M | $119.6M | ||
| Q1 25 | $72.0M | $103.9M | ||
| Q4 24 | $72.8M | — | ||
| Q3 24 | $67.5M | — | ||
| Q2 24 | $71.0M | — | ||
| Q1 24 | $75.2M | — |
净利润ANGORHLD
| Q4 25 | $-6.3M | $-1.7M | ||
| Q3 25 | $-10.9M | $-231.0K | ||
| Q2 25 | $-6.0M | $-611.0K | ||
| Q1 25 | $-4.4M | $-3.4M | ||
| Q4 24 | $-10.7M | — | ||
| Q3 24 | $-12.8M | — | ||
| Q2 24 | $-13.4M | — | ||
| Q1 24 | $-187.7M | — |
毛利率ANGORHLD
| Q4 25 | 56.4% | 55.7% | ||
| Q3 25 | 55.3% | 59.0% | ||
| Q2 25 | 52.7% | 57.5% | ||
| Q1 25 | 54.0% | 52.5% | ||
| Q4 24 | 54.8% | — | ||
| Q3 24 | 54.4% | — | ||
| Q2 24 | 54.3% | — | ||
| Q1 24 | 47.7% | — |
营业利润率ANGORHLD
| Q4 25 | -7.7% | 30.2% | ||
| Q3 25 | -14.1% | 34.3% | ||
| Q2 25 | -7.2% | 34.0% | ||
| Q1 25 | -13.9% | 24.7% | ||
| Q4 24 | -15.2% | — | ||
| Q3 24 | -19.4% | — | ||
| Q2 24 | -20.4% | — | ||
| Q1 24 | -265.9% | — |
净利率ANGORHLD
| Q4 25 | -8.0% | -1.5% | ||
| Q3 25 | -14.4% | -0.2% | ||
| Q2 25 | -7.5% | -0.5% | ||
| Q1 25 | -6.1% | -3.2% | ||
| Q4 24 | -14.7% | — | ||
| Q3 24 | -19.0% | — | ||
| Q2 24 | -18.9% | — | ||
| Q1 24 | -249.7% | — |
每股收益（稀释后）ANGORHLD
| Q4 25 | $-0.15 | $-0.20 | ||
| Q3 25 | $-0.26 | $-0.03 | ||
| Q2 25 | $-0.15 | $-0.07 | ||
| Q1 25 | $-0.11 | $-0.39 | ||
| Q4 24 | $-0.26 | — | ||
| Q3 24 | $-0.31 | — | ||
| Q2 24 | $-0.35 | — | ||
| Q1 24 | $-4.67 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $41.6M | $205.5M |
| 总债务越低越好 | — | $169.8M |
| 股东权益账面价值 | $176.3M | $6.5M |
| 总资产 | $269.7M | $333.4M |
| 负债/权益比越低杠杆越低 | — | 26.03× |
8季度趋势，按日历期对齐
现金及短期投资ANGORHLD
| Q4 25 | $41.6M | $205.5M | ||
| Q3 25 | $38.8M | $148.0M | ||
| Q2 25 | $55.9M | $99.9M | ||
| Q1 25 | $44.8M | $71.0M | ||
| Q4 24 | $54.1M | — | ||
| Q3 24 | $55.0M | — | ||
| Q2 24 | $76.1M | — | ||
| Q1 24 | $78.5M | — |
总债务ANGORHLD
| Q4 25 | — | $169.8M | ||
| Q3 25 | — | $173.4M | ||
| Q2 25 | — | $177.1M | ||
| Q1 25 | — | $180.7M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $0 | — | ||
| Q1 24 | — | — |
股东权益ANGORHLD
| Q4 25 | $176.3M | $6.5M | ||
| Q3 25 | $178.9M | $10.8M | ||
| Q2 25 | $183.0M | $9.6M | ||
| Q1 25 | $185.9M | $8.9M | ||
| Q4 24 | $186.8M | — | ||
| Q3 24 | $196.6M | — | ||
| Q2 24 | $205.6M | — | ||
| Q1 24 | $218.7M | — |
总资产ANGORHLD
| Q4 25 | $269.7M | $333.4M | ||
| Q3 25 | $265.6M | $293.2M | ||
| Q2 25 | $280.1M | $253.3M | ||
| Q1 25 | $285.4M | $214.3M | ||
| Q4 24 | $291.6M | — | ||
| Q3 24 | $293.6M | — | ||
| Q2 24 | $317.7M | — | ||
| Q1 24 | $324.8M | — |
负债/权益比ANGORHLD
| Q4 25 | — | 26.03× | ||
| Q3 25 | — | 16.01× | ||
| Q2 25 | — | 18.42× | ||
| Q1 25 | — | 20.38× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.00× | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $4.7M | $196.1M |
| 自由现金流经营现金流 - 资本支出 | $4.2M | $189.2M |
| 自由现金流率自由现金流/营收 | 5.3% | 160.8% |
| 资本支出强度资本支出/营收 | 0.5% | 5.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-9.3M | $313.2M |
8季度趋势，按日历期对齐
经营现金流ANGORHLD
| Q4 25 | $4.7M | $196.1M | ||
| Q3 25 | $-15.9M | $59.6M | ||
| Q2 25 | $18.8M | $48.9M | ||
| Q1 25 | $-13.2M | $18.4M | ||
| Q4 24 | $2.5M | — | ||
| Q3 24 | $-18.3M | — | ||
| Q2 24 | $5.0M | — | ||
| Q1 24 | $-12.5M | — |
自由现金流ANGORHLD
| Q4 25 | $4.2M | $189.2M | ||
| Q3 25 | $-16.6M | $58.6M | ||
| Q2 25 | $18.0M | $47.5M | ||
| Q1 25 | $-15.0M | $17.8M | ||
| Q4 24 | $1.7M | — | ||
| Q3 24 | $-19.3M | — | ||
| Q2 24 | $4.4M | — | ||
| Q1 24 | $-13.1M | — |
自由现金流率ANGORHLD
| Q4 25 | 5.3% | 160.8% | ||
| Q3 25 | -22.0% | 48.5% | ||
| Q2 25 | 22.5% | 39.7% | ||
| Q1 25 | -20.8% | 17.1% | ||
| Q4 24 | 2.3% | — | ||
| Q3 24 | -28.7% | — | ||
| Q2 24 | 6.2% | — | ||
| Q1 24 | -17.5% | — |
资本支出强度ANGORHLD
| Q4 25 | 0.5% | 5.8% | ||
| Q3 25 | 1.0% | 0.8% | ||
| Q2 25 | 1.0% | 1.2% | ||
| Q1 25 | 2.5% | 0.6% | ||
| Q4 24 | 1.1% | — | ||
| Q3 24 | 1.6% | — | ||
| Q2 24 | 0.8% | — | ||
| Q1 24 | 0.8% | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ANGO
| Med Device | $37.2M | 47% |
| Med Tech | $30.4M | 38% |
| Other | $11.8M | 15% |
RHLD
暂无分部数据
